fda compounding semaglutide enforcement news november 2025 Chinese companies turn to generics as shipments behind US weight-loss craze fade Judge Upholds FDA Deadline Ending

Semaglutide injection is a once-weekly injection that is given under the skin

Nine studies reported changes in body weight, with the most substantial reductions observed in comparisons against placebo

The study analyzed fasting plasma samples obtained from two previously conducted phase 2 randomized controlled trials (RCTs)

the insulin gene is only transcribed to mRNA in these cells

Earlier this year, a Super Bowl ad from the company touted the benefits of its weight-loss medications but didn't list any of their side effects or potential harms

potential differences in subgroup responses (e.g., with insulin resistance or obesity)